Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical Information.
Tefferi A, Gangat N, Mudireddy M, Lasho TL, Finke C, Begna KH, Elliott MA, Al-Kali A, Litzow MR, Hook CC, Wolanskyj AP, Hogan WJ, Patnaik MM, Pardanani A, Zblewski DL, He R, Viswanatha D, Hanson CA, Ketterling RP, Tang JL, Chou WC, Lin CC, Tsai CH, Tien HF, Hou HA. Tefferi A, et al. Among authors: zblewski dl. Mayo Clin Proc. 2018 Oct;93(10):1363-1374. doi: 10.1016/j.mayocp.2018.04.013. Epub 2018 Jun 14. Mayo Clin Proc. 2018. PMID: 29866419
Hypomethylating agents (HMAs) effect on myelodysplastic/myeloproliferative neoplasm unclassifiable (MDS/MPN-U): single institution experience.
Al-Kali A, Abou Hussein AK, Patnaik M, Zblewski D, Gangat N, Hashmi S, Elliott M, Hogan W, Litzow M. Al-Kali A, et al. Among authors: zblewski d. Leuk Lymphoma. 2018 Nov;59(11):2737-2739. doi: 10.1080/10428194.2018.1436705. Epub 2018 Feb 21. Leuk Lymphoma. 2018. PMID: 29465270 Clinical Trial. No abstract available.
Prognostic impact of combined NPM1+/FLT3- genotype in patients with acute myeloid leukemia with intermediate risk cytogenetics stratified by age and treatment modalities.
Hefazi M, Siddiqui M, Patnaik M, Wolanskyj A, Alkhateeb H, Zblewski D, Elliott M, Hogan W, Litzow M, Al-Kali A. Hefazi M, et al. Among authors: zblewski d. Leuk Res. 2015 Sep 3:S0145-2126(15)30372-6. doi: 10.1016/j.leukres.2015.09.001. Online ahead of print. Leuk Res. 2015. PMID: 26410460
Mayo Clinic experience with 1123 adults with acute myeloid leukemia.
Begna KH, Ali W, Naseema Gangat, Elliott MA, Al-Kali A, Litzow MR, Christopher Hook C, Wolanskyj-Spinner AP, Hogan WJ, Patnaik MM, Pardanani A, Zblewski DL, Chen D, He R, Viswanatha D, Hanson CA, Ketterling RP, Tefferi A. Begna KH, et al. Among authors: zblewski dl. Blood Cancer J. 2021 Mar 2;11(3):46. doi: 10.1038/s41408-021-00435-1. Blood Cancer J. 2021. PMID: 33654065 Free PMC article.
Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients.
Coston T, Pophali P, Vallapureddy R, Lasho TL, Finke CM, Ketterling RP, Carr R, Binder M, Mangaonkar AA, Gangat N, Al-Kali A, Litzow M, Zblewski D, Pardanani A, Tefferi A, Patnaik MM. Coston T, et al. Among authors: zblewski d. Am J Hematol. 2019 Jul;94(7):767-779. doi: 10.1002/ajh.25488. Epub 2019 May 3. Am J Hematol. 2019. PMID: 30964202 Free article. Clinical Trial.
Characteristics of patients with myelodysplastic syndrome with balanced translocations.
Joshi M, Greipp P, Ball C, Vinod Shah M, Khurana A, Yogarajah M, Nguyen P, He R, Viswanatha D, Jevremovic D, Salama M, Alkhateeb HB, Gangat N, Patnaik M, Begna K, Hogan W, Zblewski D, Litzow M, Al-Kali A. Joshi M, et al. Among authors: zblewski d. Br J Haematol. 2020 Jul;190(2):244-248. doi: 10.1111/bjh.16551. Epub 2020 Mar 17. Br J Haematol. 2020. PMID: 32181489 Free article. No abstract available.
26 results